Editor in Chief Dr KK Aggarwal, Padma Shri Awardee Dated:26 July,2020
Health dept to conduct Covid-19 testing at 28 centres
Agra: Following orders of the state government to increase Covid-19 testing, the Agra district health department has established rapid antigen testing facility at 28 centres in the district. Around 10 testing facilities will operate at 10 different primary health centres (PHC) in the city areas and 18 community health centres (CHC) in rural areas. Tests will be conducted after screening of the symptomatic patient.
Convalescent Plasma Therapy in COVID-19
Join us today at 7:00 pm as we discuss the management of COVID-19 patients with "convalescent plasma therapy
” in Medtalks with Dr KK Aggarwal COVID edition
CMAAO Coronavirus Facts and Myth Buster: COVID Drugs Update
With inputs from Dr Monica Vasudev
World COVID Meter 25th July: India Number 3, 213 Countries Affected
Cases: 1M April 2, 2M April 15, 3M April 27, 4M May 8, 5M May 20, 6M May 30, 7M June 7, 8M June 15, 9M June 22, 10M June 29th, 11M July 4, 12M July 8, 13M July 13, 14M July 17, 15M July 23
You look at people the same way as you are
Honest people regard everybody as honest and dishonest people regard everybody as dishonest. It all depends on the type of people you interact with. If you do not take bribe, nobody will come and offer bribe to you and you will feel everybody is honest. If you take bribe then everybody will come to you to offer bribe and you will feel that everybody in the society is dishonest.
Video of The day
Healthcare News Monitor
Immunity booster and vitamin continue to be in purchase preference
Cipla Ltd has received Indian regulatory approval to sell anti-viral drug favipiravir to treat Covid-19, the drugmaker said on Friday, as coronavirus infections in the world's third worst-hit nation show no sign of abating. ,The Drug Controller General of India granted Cipla accelerated approval to make and sell favipiravir in an effort to meet the "urgent and unmet" need for Covid-19 treatment options in the country, the company said. ,Indian drugmakers including Glenmark Pharmaceuticals Ltd are racing to supply generic versions of favipiravir, originally developed by Japan's Fujifilm Holdings Corp as Avigan for treating influenza.
How a team of doctors in Kochi saved a 5-year-old with rare ‘P null’ blood group
At the end of April this year, Dr Veena Shenoy and her team at the Department of Transfusion Medicine at the Amrita Institute of Medical Sciences (AIMS), Kochi, handled the case of a five-year-old patient from Gujarat who had suffered a serious fall and was in need of surgery. Dr Veena looked at the child’s reports and saw something which she had until then only seen in medical textbooks and journals: P null phenotype. ,“The hospital in Surat got the child’s sample tested from the New York Blood Centre and she was then brought to Kerala for further treatment,” Dr Veena tells TNM.